| 原发性硬化性胆管炎的治疗进展 |
| |
| 引用本文： | 鲍正华,韩真. 原发性硬化性胆管炎的治疗进展[J]. 临床肝胆病杂志, 2011, 27(6): 663-666 |
| |
| 作者姓名： | 鲍正华 韩真 |
| |
| 作者单位： | 皖南医学院弋矶山医院消化内科,安徽芜湖,241000 |
| |
| 摘 要： | 原发性硬化性胆管炎（PSC）是一种原因不明的慢性胆汁淤积性自身免疫性肝病,其确切的发病机制尚未明确,可能与遗传、免疫、损伤等多种因素有关,诊断及治疗均较为困难。本文就原发性硬化性胆管炎的治疗作一综述,以期加深对该病的了解,为进一步的临床治疗提供依据
|
| 关 键 词： | 胆管炎 硬化性 |
Progress in the treatment of primary sclerosing cholangitis |
| |
| BAO Zheng-hua,HAN Zhen. Progress in the treatment of primary sclerosing cholangitis[J]. Chinese Journal of Clinical Hepatology, 2011, 27(6): 663-666 |
| |
| Authors: | BAO Zheng-hua HAN Zhen |
| |
| Affiliation: | BAO Zheng-hua,HAN Zhen.(Department of Gastroenterology,Yijishan Hospital of Wannan Medical College,Wuhu,Anhui 241000,China) |
| |
| Abstract: | Primary sclerosing cholangitis is a chronic autoimmune cholestatic liver disease with unclear etiology,which may refer to genetics,immunology and injury factors.It is very difficult to diagnose and treat.This article introduces the studies of the therapy of PSC to further understand the disease of PSC and provide new evidences for treating PSC. |
| |
| Keywords: | cholangitis sclerosing |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
